Gastrointestinal microbiota of healthy subjects produces nontoxic amounts of EE from 1 0 2 luminal dietary carbohydrates. Next, EE is absorbed and metabolized in the liver to 1 0 3 ACD, which in turn is oxidized to non-toxic amounts of acetate [16] . In contrast, in [19], gut production of EE is significantly greater than in controls [4] [5] [6] . Agreeing with 1 0 6 this, gut/fecal concentrations of EE in these cases are proportionally equal to or even 1 0 7 greater than those obtained after moderate drinking [19] [20] [21] As ethanol is formed within 1 0 8 a dysbiotic gut, it is converted to ACD in a dose-and concentration-dependent manner 1 0 9
[11]. In this setting, ACD-producing alcohol dehydrogenase (ADH) activity is higher 1 1 0 than that of ACD-oxidizing aldehyde dehydrogenase (ALDH) [22] . The net result is 1 1 1 ACD build-up coupled with low BACs. However, in the auto-brewery syndrome, 1 1 2 massive production of EE exceeds gut-liver axis ability to clear alcohol from 1 1 3 circulation. As a consequence, BAC may reach 250-350 mg/dL [23] . Blind-loop contents of rat jejunum converts ethanol to ACD at a rate of 1.99 µM/min • 1 1 5 mL under aerobic conditions [11] . If applicable to patients with SIBO and small bowel 1 1 6 contents around 2000 mL, it is estimated that everyone can convert ~528 g of EE into 1 1 7 ACD daily. Experimentally it has been demonstrated that extrahepatic ACD is 30 to 1 1 8 330-fold more hepatotoxic than that formed intrahepatically [24, 25] . Extrapolating this 1 1 9 to humans, 0.18-2 g of EE will provide an amount of ACD as hepatotoxic as that 1 2 0 generated intrahepatically from a cirrhotogenic dose of 60 g ethanol [26] . Lastly, a seminal study showed up-regulation of all genes involved in ethanol 1 2 6 metabolism in nonalcoholic steatohepatitis livers [5] . Importantly, these genes encode 1 2 7 enzymes those maximal catalytic activities are at high ethanol concentrations [29] . Even 1 2 8 more noteworthy is the finding that hepatic expression of ethanol-metabolizing genes in 1 2 9 NAFLD/PCOS is similar to that of alcoholic hepatitis [7] . Blood-alcohol elimination rate may be 3-fold to 4-fold higher in alcohol-tolerant than in tolerance/adaptation process [33, 34] . In this setting, instead of metabolizing ethanol in 1 4 0 milligram levels through ADH1 activity, the individual starts doing this at tens of grams Interestingly, and probably not by chance, all these risk factors for increased blood- alcohol clearance are also present in NAFLD/PCOS [5, [38] [39] [40] . For this reason, it is producing and -degrading bacteria [4, 41, 42] , (ii) gut production and degradation of 1 5 0 ethanol are dose-dependent and simultaneous processes that prevent high BAC 1 5 1 [11, 19, 43, 44] , and (iii) gut concentrations of ACD reach mutagenic values (49-87 µM) Calculating EE production from a standard human pharmacokinetic model 1 5 8
Ethanol pharmacokinetics in NAFLD/PCOS is similar to that of alcohol-tolerant
One study showed that average BAC of twenty patients with NAFLD was 7.14 mg/dL 1 5 9 after a 12h overnight fast [27] . Assuming that ethanol elimination rate of these 1 6 0 individuals was 20 mg/dL/h and that its mean height was 1.74 m, we estimate the 1 6 1 amount of EE produced by each patient. To achieve this, we use a validated 1 6 2 8 physiologically-based model of alcohol metabolism, which has been described in detail 1 6 3 elsewhere [28] . According to our calculations, each patient produced 161.49 g of EE 1 6 4 after a 12-h overnight fast. By extrapolating the data to three equicaloric meals, the 1 6 5 daily production of EE should reach 484 g. Because EE undergoes extensive conversion 1 6 6 to ACD in the gut-liver axis, estimated total circulating alcohol burden is only 4.6 g. This leads to the characteristically low BAC found in these patients (see [28] for 1 6 8 equations and calculation procedures). It has been shown that endogenous ACD is formed as a byproduct during normal 1 7 1 ovarian steroidogenesis [50] . In this situation, there is no ovotoxicity because it gonadotropin-stimulated gonadal hormone production [51, 52] . This leads to an increase 1 7 7 in the number of the corpora lutea, atretic follicles, regression of theca antral follicles, 1 7 8 vacuolation/fat deposition in granulosa, theca, and interstitial cells [53] . As a result, Agreeing with these observations, the odds ratio of having PCOS is about 30-fold In short, our data reconcile the apparently contradictory association between exposure to our hypothesis may contribute to novel therapeutic and preventive strategies for disease 2 1 2 management and control. [28] Medeiros IC de, de Lima JG. Is nonalcoholic fatty liver disease an endogenous Delayed gastric emptying in the obese: an assessment using the non-invasive Overgrowth. J Clin Gastroenterol 2015;49:571-6. identified genes associated with ovarian cancer progression. Int J Oncol
